Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Melanoma & Colorectal

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Apr 12, 2021 10:00am

83 Views

Post# 32976687

RE:RE:RE:RE:Melanoma & Colorectal

realitycheck4u
I was hoping you would be wrong and afraid you would be correct, how can this SP possible negative today?

realitycheck4u wrote:
My guess is a close that is up just a dime or two tomorrow followed by Paul starting to realize that they need serious help because the same thing is going to happen over and over. Even if it does go up more throughout the week, or later, it's just not what it should be. Paul should be hoeing the absolute best drug marketers in the USA right now and stop pioneering. Bring in the A team.

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver